These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34758015)

  • 21. Chronic kidney disease and undiagnosed atrial fibrillation in individuals with diabetes.
    Heo NJ; Rhee SY; Waalen J; Steinhubl S
    Cardiovasc Diabetol; 2020 Sep; 19(1):157. PubMed ID: 32998739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic kidney disease predicts atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Șerban RC; Șuș I; Lakatos EK; Demjen Z; Ceamburu A; Fișcă PC; Somkereki C; Hadadi L; Scridon A
    Acta Cardiol; 2019 Dec; 74(6):472-479. PubMed ID: 30650039
    [No Abstract]   [Full Text] [Related]  

  • 23. Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities.
    Chao TF; Lip GYH; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Chen SA
    Eur Heart J; 2019 May; 40(19):1504-1514. PubMed ID: 30605505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients.
    Romiti GF; Corica B; Pipitone E; Vitolo M; Raparelli V; Basili S; Boriani G; Harari S; Lip GYH; Proietti M;
    Eur Heart J; 2021 Sep; 42(35):3541-3554. PubMed ID: 34333599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ischemic heart disease-related mortality in Brazil, 2006 to 2020. A study of multiple causes of death.
    Bastos LAVM; Villela PB; Bichara JLP; do Nascimento EM; Bastos ELVM; de B Pereira B; Oliveira GMM
    BMC Public Health; 2024 Mar; 24(1):849. PubMed ID: 38504228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comorbidities in heart failure patients that predict cardiovascular readmissions within 100 days-An observational study.
    Scholten M; Davidge J; Agvall B; Halling A
    PLoS One; 2024; 19(1):e0296527. PubMed ID: 38165943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial Fibrillation.
    Claxton JS; Chamberlain AM; Lutsey PL; Chen LY; MacLehose RF; Bengtson LGS; Alonso A
    Am J Med; 2020 Oct; 133(10):e554-e567. PubMed ID: 32320695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
    J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study.
    Potpara TS; Stankovic GR; Beleslin BD; Polovina MM; Marinkovic JM; Ostojic MC; Lip GYH
    Chest; 2012 Feb; 141(2):339-347. PubMed ID: 21622553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Ullal AJ; Kaiser DW; Fan J; Schmitt SK; Than CT; Winkelmayer WC; Heidenreich PA; Piccini JP; Perez MV; Wang PJ; Turakhia MP
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):39-48. PubMed ID: 27782345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CHA2DS2-VASc score for ischaemic stroke risk stratification in patients with chronic obstructive pulmonary disease with and without atrial fibrillation: a nationwide cohort study.
    Hu WS; Lin CL
    Europace; 2018 Apr; 20(4):575-581. PubMed ID: 28407109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Bansal N; Xie D; Sha D; Appel LJ; Deo R; Feldman HI; He J; Jamerson K; Kusek JW; Messe S; Navaneethan SD; Rahman M; Ricardo AC; Soliman EZ; Townsend R; Go AS
    J Am Soc Nephrol; 2018 Dec; 29(12):2859-2869. PubMed ID: 30377231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of obesity, hypertension, diabetes mellitus, alcohol, and sleep apnea on the risk of atrial fibrillation.
    Čarná Z; Osmančík P
    Physiol Res; 2021 Dec; 70(Suppl4):S511-S525. PubMed ID: 35199540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis.
    Li HL; Lip GYH; Feng Q; Fei Y; Tse YK; Wu MZ; Ren QW; Tse HF; Cheung BY; Yiu KH
    Cardiovasc Diabetol; 2021 May; 20(1):100. PubMed ID: 33962654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-cardiac comorbidities in heart failure: an update on diagnostic and management strategies.
    Kodur N; Tang WHW
    Minerva Med; 2024 Jun; 115(3):337-353. PubMed ID: 38899946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Bansal N; Zelnick LR; Soliman EZ; Anderson A; Christenson R; DeFilippi C; Deo R; Feldman HI; He J; Ky B; Kusek J; Lash J; Seliger S; Shafi T; Wolf M; Go AS; Shlipak MG;
    Am J Kidney Dis; 2021 Jun; 77(6):907-919. PubMed ID: 33309861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart Survey.
    Guerra F; Brambatti M; Nieuwlaat R; Marcucci M; Dudink E; Crijns HJGM; Matassini MV; Capucci A
    Europace; 2017 Dec; 19(12):1922-1929. PubMed ID: 29106537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation.
    Durheim MT; Holmes DN; Blanco RG; Allen LA; Chan PS; Freeman JV; Fonarow GC; Go AS; Hylek EM; Mahaffey KW; Pokorney SD; Reiffel JA; Singer DE; Peterson ED; Piccini JP
    Heart; 2018 Nov; 104(22):1850-1858. PubMed ID: 29875139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.